All Stories

Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline

The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment options to patients with autoimmune disorders like Graves' disease.

Apr 8, 2025 - 16:07
 0
Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline
The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment options to patients with autoimmune disorders like Graves' disease.
Read More

Tags:

Previous Article

J&J links FcRn blocker to sustained benefits as FDA ruling on potential blockbus...

Next Article

STAT+: As more patients get automated test results, researchers seek ways to cal...

Related Posts

Vaccine-probiotic combo prevents, clears bacterial gut infections in mice in antibiotic alternative test

Vaccine-probiotic combo prevents, clears bacterial gut ...

Apr 9, 2025  0

Eisai's abandoned Enhertu challenger set to live on at BlissBio

Eisai's abandoned Enhertu challenger set to live on at ...

Mar 21, 2025  0

Merck KGaA fails midphase lupus trial arm, says totality of data support further development

Merck KGaA fails midphase lupus trial arm, says totalit...

Mar 7, 2025  0